According to recent findings from a phase 3 trial, the immunotherapy Tecentriq (atezolizumab) improved survival compared with docetaxel in patients with advanced non–small cell lung cancer (NSCLC) following the failure of platinum-based chemotherapy.
Approximately 46 percent of patients with breast cancer at high risk for recurrence but low genomic risk according to the 70-gene breast cancer recurrence assay (MammaPrint) might not require adjuvant chemotherapy.
Colorectal cancer mortality rates have been on the decline in California for both men and women since the mid-1990s, but for Hispanic men, rates have remained essentially unchanged. A new study suggests that lower rates of screening may be the driver of this disparity.
Learning to navigate breast cancer is easier with someone by your side.
Banding together with my large family had a positive effect not only on my brother, a patient, but on all of us.
The FDA has approved Blincyto (blinatumomab) for the treatment of pediatric and adolescent patients with Philadelphia chromosome-negative (Ph-) relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).
Women who are unable to travel to genetic counselors may be able to reap the same benefits over the phone, according to a recent study.
This dynamic suggests an important area of focus for oncologists and other health care professionals who provide care for the nation’s growing population of cancer survivors.
One of the methods my wife and I developed to ward of the cynicism that comes when faced with such an unrelenting foe is something we call "playing the cancer card."
Two-time cancer survivor suspects survivors look at the material stuff or clutter of life differently since their cancer diagnosis.
Pacritinib decreased spleen size, but did not improve total symptom scores in a group of patients with myelofibrosis.
Arzerra was approved in combination with fludarabine and cyclophosphamide to treat patients with CLL.
What happens when chemotherapy ends?
While it is obvious that we will think of cancer, it is how we do so that matters.
The month of October has been chosen as the symbolic month for breast cancer awareness, but that doesn't mean all cancer survivors embrace it.
Sometimes it seems like being heroic after you get sick is expected of you. To me, putting goodness into the world, in sickness or in health, is what makes heroes.
Facing uncertainty, we have choices between fear, stress and anxiety or magic.
Male breast cancer survivor Khevin Barnes asked a lot of questions — but he forgot to ask this one.
Focusing on recurrence after a cancer diagnosis can be overwhelming, but it doesn't have to be.
The facts and figures of what the trajectory of a melanoma diagnosis looks like.
There’s a rhythm to life in the hospital, a daily hum of activity, but it’s not the kind of routine Lindsay Kahn ever expected be a part of, especially not at her age.
While cancer may be a part of a survivor's identity, there are other aspects, too.
Will AFIB come back during the third chemo cycle?
Where do you store your issues, tension, stress and emotion? And what are you doing to release it so it doesn’t turn into something worse?
Being insured by Medicaid may affect the prognosis of a patient with GBM, according to a recent study.
There is no right way to celebrate (or not celebrate) a cancerversary.
Greg continues his treatment journey for GBM.
I remember that moment feeling like I was in the middle of a fire, and it was going to eat me alive. But it did not. I found a way to get up; I found a way to rise up.
